on 25 Aug 2023
Last Applicant/ Owned by
Ole Maaløes Vej 3DK-2200 København N
DK
Serial Number
79180936 filed on 01st Dec 2015
Registration Number
5139414 registered on 14th Feb 2017
Correspondent Address
John Paul Oleksiuk
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Industrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector Chemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; wi Read More
Industrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector
N/A
N/A
Pharmaceutical and medical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; chemical-pharmaceutical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; diagnostic preparations for medical purposes; reagents for medical purposes and for research; preparations for analysis for medical and research purposes for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; all of the aforementioned with the exclusion of veterinary preparations and ingredients, supplements for food, and medicated foodstuffs for animals
N/A
N/A
Chemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; with the exclusion of chemicals used in the food industry and animal food industry and ingredients for foodstuffs for animals
N/A
N/A
No 79180936
No Service Mark
No 336232-20024
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
27th May 2024 | TOTAL INVALIDATION PROCESSED BY THE IB |
06th May 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
06th May 2024 | INVALIDATION PROCESSED |
25th Apr 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
25th Aug 2023 | CANCELLED SECTION 71 |
10th Jul 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
14th Feb 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
12th Jun 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
08th Jun 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
08th Jun 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |